The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
PI3K/Akt signaling in osteosarcoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ren, W., Liu, Y., Wan, S., Chang, F., Wang, W., Chen, Y., Zhang, Z., Wang, T., Wang, J., Zhou, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096816 · Cited by 66
Self-citationRetractedMicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN
Shen, L., Chen, X.-D., & Zhang, Y.-H. (2013) · Tumor Biology · doi:10.1007/s13277-013-1274-1 · Cited by 65
RetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Targeting PI3K/Akt/mTOR Signaling in Cancer
Porta, C., Paglino, C., & Mosca, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00064 · Cited by 1,485
Osteosarcoma treatment – Where do we stand? A state of the art review
Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,234
Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.019 · Cited by 1,091
Targeting PI3K/mTOR Signaling in Cancer
Arcaro, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00084 · Cited by 1,024
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
Paplomata, E., & O’Regan, R. (2014) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834014530023 · Cited by 593
Osteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W.-X., Luo, J., Haydon, R. C., & He, T.-C. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 357
Lehmann, B. D., Bauer, J. A., Schafer, J. M., Pendleton, C. S., Tang, L., Johnson, K. C., Chen, X., Balko, J. M., Gómez, H., Arteaga, C. L., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0406-x · Cited by 342
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
Hsieh, A., & Edlind, M. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122876 · Cited by 276
Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature
Millimouno, F. M., Dong, J., Yang, L., Li, J., & Li, X. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0136 · Cited by 272
Chawla, S. P., Staddon, A. P., Baker, L. H., Schuetze, S. M., Tolcher, A. W., D'Amato, G. Z., Blay, J.-Y., Mita, M. M., Sankhala, K. K., Berk, L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6329 · Cited by 246
Sarcomas in TP53 germline mutation carriers: A review of the IARC TP53 database
Ognjanovic, S., Olivier, M., Bergemann, T. L., & Hainaut, P. (2012) · Cancer · doi:10.1002/cncr.26390 · Cited by 238
Molecular mechanisms of chemoresistance in osteosarcoma (Review)
HE, H., NI, J., & HUANG, J. (2014) · Oncology Letters · doi:10.3892/ol.2014.1935 · Cited by 234
Zhao, G., Cai, C., Yang, T., Qiu, X., Liao, B., Li, W., Ji, Z., Zhao, J., Zhao, H., Guo, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053906 · Cited by 226
Rubashkin, M. G., Cassereau, L., Bainer, R., DuFort, C. C., Yui, Y., Ou, G., Paszek, M. J., Davidson, M. W., Chen, Y.-Y., & Weaver, V. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3698 · Cited by 205
Ahmad, A., Biersack, B., Li, Y., Kong, D., Bao, B., Schobert, R., Padhye, S., & Sarkar, F. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990078 · Cited by 200
Boreddy, S. R., Pramanik, K. C., & Srivastava, S. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1891 · Cited by 193
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Dobbin, Z., & Landen, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048213 · Cited by 191
Spoerke, J. M., O'Brien, C., Huw, L., Koeppen, H., Fridlyand, J., Brachmann, R. K., Haverty, P. M., Pandita, A., Mohan, S., Sampath, D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2347 · Cited by 182
Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
Bulut, G., Hong, S.-H., Chen, K., Beauchamp, E. M., Rahim, S., Kosturko, G. W., Glasgow, E., Dakshanamurthy, S., Lee, H.-S., Daar, I., et al. (2012) · Oncogene · doi:10.1038/onc.2011.245 · Cited by 179
Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer
Hernandez-Aya, L. F., & Gonzalez-Angulo, A. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0402 · Cited by 177
Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease
Matsuda, S., Kobayashi, M., & Kitagishi, Y. (2013) · ISRN Endocrinology · doi:10.1155/2013/472432 · Cited by 165
NVP-BEZ235 as a New Therapeutic Option for Sarcomas
Manara, M. C., Nicoletti, G., Zambelli, D., Ventura, S., Guerzoni, C., Landuzzi, L., Lollini, P., Maira, S.-M., García-Echeverría, C., Mercuri, M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0816 · Cited by 159
Advances in targeted therapy for osteosarcoma.
Zhou, W., Hao, M., Du, X., Chen, K., Wang, G., & Yang, J. (2014) · PubMed · Cited by 138
Highlights of the Latest Advances in Research on CDK Inhibitors
Cicenas, J., Kalyan, K. P., Sorokinas, A., Jatulyte, A., Valiūnas, D., Kaupinis, A., & Valius, M. (2014) · Cancers · doi:10.3390/cancers6042224 · Cited by 135
Perissinotto, E., Cavalloni, G., Leone, F., Fonsato, V., Mitola, S. M. F., Grignani, G., Surrenti, N., Sangiolo, D., Bussolino, F., Piacibello, W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.490.11.2 · Cited by 135
Review of the Molecular Pathogenesis of Osteosarcoma
He, J., Hao, Y. X., Wang, X., Yang, X.-J., Shao, J., Guo, F.-J., & Feng, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.15.5967 · Cited by 131
Liao, C., Lai, K., Huang, A., Yang, J., Lin, J., Wu, S., Wood, W. G., Lin, J., & Chung, J. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.02.033 · Cited by 121
Pignochino, Y., Dell’Aglio, C., Basiricò, M., Capozzi, F., Soster, M., Marchiò, S., Bruno, S., Gammaitoni, L., Sangiolo, D., Torchiaro, E., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2293 · Cited by 112
Anti-apoptotic BCL-2 family proteins in acute neural injury
Anilkumar, U., & Prehn, J. H. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00281 · Cited by 112
Bagatell, R., Norris, R. E., Ingle, A. M., Ahern, C. H., Voss, S. D., Fox, E., Little, A., Weigel, B. J., Adamson, P. C., & Blaney, S. M. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24874 · Cited by 105
Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling
Atif, F., Yousuf, S., & Stein, D. G. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.007 · Cited by 104
Link between PI3K/AKT/PTEN Pathway and NOX Proteinin Diseases
Nakanishi, A., Wada, Y., Kitagishi, Y., & Matsuda, S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500203 · Cited by 101
Tumor Suppressor PTEN is Mutated in Canine Osteosarcoma Cell Lines and Tumors
Levine, R. A., Forest, T. W., & Smith, C. (2002) · Veterinary Pathology · doi:10.1354/vp.39-3-372 · Cited by 101
Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo
Zhu, Q., Yang, J., Han, S., Liu, J., Holzbeierlein, J. M., Thrasher, J. B., & Li, B. (2010) · The Prostate · doi:10.1002/pros.21300 · Cited by 98
Li, G., Cai, M., Fu, D., Chen, K., Sun, M., Cai, Z., & Cheng, B. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000343336 · Cited by 98
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · PubMed · doi:10.1002/(sici)1097-4644(199610)63:1%3c37::aid-jcb3%3e3.0.co;2-0 · Cited by 98
Takagi, S., Takemoto, A., Takami, M., Oh‐hara, T., & Fujita, N. (2014) · Cancer Science · doi:10.1111/cas.12464 · Cited by 92
Majchrzak, A., Witkowska, M., & Smolewski, P. (2014) · Molecules · doi:10.3390/molecules190914304 · Cited by 89
Oncogene alterations in primary, recurrent, and metastatic human bone tumors
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · Journal of Cellular Biochemistry · Cited by 87
Guijarro, M. V., Ghivizzani, S. C., & Gibbs, C. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00189 · Cited by 86
MicroRNA function and dysregulation in bone tumors: the evidence to date
Nugent, M. (2014) · Cancer Management and Research · doi:10.2147/cmar.s53928 · Cited by 86
Krishnan, K., Bruce, B., Hewitt, S. M., Thomas, D. G., Khanna, C., & Helman, L. J. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9033-y · Cited by 84
Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells
Jin, S., Pang, R., Shen, J.-N., Huang, G., Wang, J., & Zhou, J. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0062-z · Cited by 84
The Rb–E2F Transcriptional Regulatory Pathway in Tumor Angiogenesis and Metastasis
Schaal, C. M., Pillai, S., & Chellappan, S. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00004-4 · Cited by 82
Bagatell, R., Beliakoff, J., David, C. L., Marron, M. T., & Whitesell, L. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20611 · Cited by 81
Zhou, R., Zhang, Z., Zhao, L., Jia, C., Xu, S., Mai, Q., Lu, M., Huang, M., Wang, L., Wang, X., et al. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21311 · Cited by 81
Appraising the Current Role of Chemotherapy for the Treatment of Sarcoma
D’Adamo, D. R. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.09.004 · Cited by 78
Gobin, B., Baud’huin, M., Lamoureux, F., Ory, B., Charrier, C., Lanel, R., Battaglia, S., Rédiní, F., Lézot, F., Blanchard, F., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29040 · Cited by 76
Blocked Autophagy by miR-101 Enhances Osteosarcoma Cell ChemosensitivityIn Vitro
Chang, Z., Huo, L., Li, K., Wu, Y.-M., & Hu, Z. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/794756 · Cited by 75
The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review)
Liao, Y., Zhou, C., Zeng, H. M., Zuo, D., Wang, Z., YIN, F., HUA, Y.-Q., & CAI, Z.-D. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1521 · Cited by 75
Sabile, A. A., Arlt, M., Muff, R., Bode, B., Langsam, B., Bertz, J., Jentzsch, T., Puskás, G. J., Born, W., & Fuchs, B. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.535 · Cited by 75
A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma
the National Osteosarcoma Etiology Study Group, Mirabello, L. J., Yu, K. F., Berndt, S. I., Burdett, L. A., Wang, Z., Chowdhury, S., Teshome, K., Uzoka, A., Hutchinson, A. A., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-209 · Cited by 75
Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
Wu, Z., Min, L., Chen, D., Hao, D., Duan, Y., Qiu, G., & Wang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014648 · Cited by 74
Liu, B., Shi, Z., Feng, J., & Tao, H. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.10.008 · Cited by 74
Tsubaki, M., Satou, T., Itoh, T., Imano, M., Ogaki, M., Yanae, M., & Nishida, S. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.01.024 · Cited by 73
Gobin, B., Battaglia, S., Lanel, R., Chesneau, J., Amiaud, J., Rédiní, F., Ory, B., & Heymann, D. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.017 · Cited by 73
Hou, C., Lin, F.-L., Tong, K.-B., Hou, S.-M., & Liu, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.010 · Cited by 72
Rokkaku, T., Kimura, R., Ishikawa, C., Yasumoto, T., Senba, M., Kanaya, F., & Mori, N. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2019 · Cited by 71
Joshi, P., Middleton, J. D., Jeon, Y.-J., & Garofalo, M. (2014) · World Journal of Methodology · doi:10.5662/wjm.v4.i2.59 · Cited by 70
PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis
Okumura, N., Yoshida, H., Kitagishi, Y., Murakami, M., Nishimura, Y., & Matsuda, S. (2012) · Advances in Hematology · doi:10.1155/2012/843085 · Cited by 69
Kuijjer, M. L., van den Akker, B. E. W. M., Hilhorst, R., Mommersteeg, M., Buddingh, E. P., Serra, M., Buerger, H., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-4 · Cited by 68
Peng, S., Lee, C., Hour, M., Tsai, S., Kuo, D., Chen, F., Shieh, P., & Yang, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2175 · Cited by 67
Human T-Cell Leukemia Virus Type 1 Infection Leads to Arrest in the G 1 Phase of the Cell Cycle
Liu, M., Yang, L., Zhang, L., Liu, B., Merling, R. K., Xia, Z., & Giam, C. (2008) · Journal of Virology · doi:10.1128/jvi.00091-08 · Cited by 65
miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression
Gao, Y., Luo, L., Li, S., & Cao, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.061 · Cited by 63
Ji, H., Ding, Z., Hawke, D. H., Xing, D., Jiang, B., Mills, G. B., & Lu, Z. (2012) · EMBO Reports · doi:10.1038/embor.2012.53 · Cited by 63
Zhang, B., Shi, Z., Liu, B., Yan, X., Feng, J., & Tao, H. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328334da17 · Cited by 63
Yang, J., Lin, C., Hsieh, Y., Cheng, H.-L., Lue, K., Yang, S., & Lu, K. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.028 · Cited by 62
Zhang, Y., Sun, S., Chen, J., Ren, P., Hu, Y., Cao, Z., Sun, H., & Ding, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1223-z · Cited by 59
Lee, J., Kim, K.-S., An, H., Kim, C., Moon, H., & Lee, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083611 · Cited by 57
Miwa, S., Sugimoto, N., Yamamoto, N., Shirai, T., Nishida, H., Hayashi, K., Kimura, H., Takeuchi, A., Igarashi, K., Yachie, A., et al. (2012) · PubMed · Cited by 57
A Critical Role for the mTORC2 Pathway in Lung Fibrosis
Chang, W., Wei, K., Ho, L. A., Berry, G. J., Jacobs, S. S., Chang, C. H., & Rosen, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106155 · Cited by 56
Cancer Stem Cells, Pluripotency, and Cellular Heterogeneity
Atlasi, Y., Looijenga, L. H. J., & Fodde, R. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416022-4.00013-5 · Cited by 55
Yao, C., Wei, J., Wang, Z., Ding, H., Li, D., Yan, S., Yang, Y., & Gu, Z. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9423-5 · Cited by 54
Mu, X., Isaac, C. E., Schott, T., Huard, J., & Weiss, K. R. (2013) · Sarcoma · doi:10.1155/2013/480713 · Cited by 53
Carol, H., Morton, C. L., Gorlick, R. G., Kolb, E. A., Keir, S. T., Reynolds, C. P., Kang, M. H., Maris, J. M., Billups, C. A., Smith, M. A., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22710 · Cited by 49
Zhang, A., He, S.-H., Sun, X., Ding, L., Bao, X., & Wang, N. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-15 · Cited by 49
Ferreira, A. C. D. S., Robaina, M. C., de Rezende, L. M. M., Severino, P., & Klumb, C. E. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2021-4 · Cited by 48
D’Arcy, P., Maruwge, W., Wolahan, B., Ma, L., & Brodin, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095136 · Cited by 44
Geng, Y., Yang, L., Zhang, C., & Kong, L. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.08.002 · Cited by 43
ZHU, L. B., Jiang, J., Zhu, X. P., Wang, T. F., Chen, X. Y., Luo, Q. F., Shu, Y., Liu, Z., & HUANG, S. H. (2014) · PubMed · Cited by 42
Liang, C., Li, H., Shen, C., Lai, J., Shi, Z., Liu, B., & Tao, H. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800617867 · Cited by 42
Liu, Y., He, J., Chen, X., Li, J., Shen, M., Yu, W.-J., Yang, Y., & Xiao, Z. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363029 · Cited by 42
TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin
Wu, J., Liao, Q., He, H., Zhong, D., & Yin, K. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21991 · Cited by 40
Fukaya, Y., Ishiguro, N., Senga, T., Ichigotani, Y., Sohara, Y., Motomu, T., Shioura, T., Iwamoto, T., & Hamaguchi, M. (2005) · Oncology Reports · doi:10.3892/or.14.4.847 · Cited by 40
Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells
Nielsen‐Preiss, S. M., Silva, S. R., & Gillette, J. M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10709 · Cited by 39
Modeling human osteosarcoma in mice through 3AB‐OS cancer stem cell xenografts
Fiore, R. D., Guercio, A., Puleio, R., Marco, P. D., Drago‐Ferrante, R., D’Anneo, A., BLASIO, A. D., Carlisi, D., Bella, S. D., Pentimalli, F., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24214 · Cited by 39
Wu, J., Wu, X., Zhong, D., Zhai, W., Ding, Z., & Zhou, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012573 · Cited by 38
Xie, Z., Xie, Y., & Dong, Q. (2013) · Oncology Letters · doi:10.3892/ol.2013.1531 · Cited by 38
Santiago‐O’Farrill, J. M., & Gordon, N. B. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_8 · Cited by 37
Kuzmanov, A., Wielockx, B., Rezaei, M., Kettelhake, A., & Breier, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.27360 · Cited by 37
Calpain‐6 is an endothelin‐1 signaling dependent protective factor in chemoresistant osteosarcoma
Marion, A., Dieudonné, F., Patiño‐García, A., Lecanda, F., Marie, P. J., & Modrowski, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26246 · Cited by 37
English, D. P.-G., Bellone, S., Cocco, E., Bortolomai, I., Pecorelli, S. L., Lopez, S., Silasi, D., Schwartz, P. E., Rutherford, T., & Santin, A. D. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.07.020 · Cited by 36
Liu, Z., MAO, J. H., Peng, A. F., Yin, Q., Zhou, Y., LONG, X. H., & HUANG, S. H. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1220 · Cited by 35
Shen, J. (2011) · Oncology Reports · doi:10.3892/or.2011.1328 · Cited by 35
Xu, X., Wang, B., & Xu, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2067 · Cited by 35
Guo, Y., Zhao, R., Ma, J., Cui, W., Sun, Z., Gao, B., He, S., Han, Y., Fan, J., Yang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090220 · Cited by 35
Li, B., Yang, Y., Jiang, S., Ni, B., Chen, K., & Jiang, L. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1617 · Cited by 35
Liang, W., Gao, B., Xu, G., Weng, D., XIE, M., & Qian, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2664 · Cited by 34
Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line
Tedesco, I., Russo, M., Bilotto, S., Spagnuolo, C., Scognamiglio, A., Palumbo, R., Nappo, A., Iacomino, G., Luigi Moio, B., & Russo, G. L. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.078 · Cited by 33
Li, B., Yang, Y., Jiang, S., Ni, B., Chen, K., & Jiang, L. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3714 · Cited by 32
Chiu, H., Wei, L., Ho, S., & Wang, Y. (2011) · Radiation Research · doi:10.1667/rr2380.1 · Cited by 32
Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
Zhang, G., Li, M., Zhu, X., Bai, Y., & Yang, C. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12052994 · Cited by 31
Liu, T., Zhou, W., Zhang, F., Shi, G., Teng, H., Xiao, J., & Wang, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2215 · Cited by 30
Targeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis
Wang, X., Lai, P., Zhang, Z., Huang, M., Wang, L., YIN, M., Jin, D.-D., Zhou, R., & Bai, X. (2014) · Oncology Reports · doi:10.3892/or.2014.3182 · Cited by 29
Chandolu, V., & Dass, C. R. (2012) · BioMed Research International · doi:10.1155/2012/740295 · Cited by 29
Zhang, K., Tian, F., Zhang, Y., Zhu, Q., Xue, N., Zhu, H., Wang, H., & Guo, X. (2013) · Tumor Biology · doi:10.1007/s13277-013-1335-5 · Cited by 29
PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
Ameln, A. K., Prade, I., Großer, M., Kettelhake, A., Rezaei, M., Chavakis, T., Flamme, I., Wielockx, B., & Breier, G. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0201 · Cited by 28
Long, X., ZHANG, G.-M., Peng, A.-F., LUO, Q.-F., ZHANG, L., Wen, H., Zhou, R., GAO, S., Zhou, Y., & Liu, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2825 · Cited by 26
Zhou, X., Yuan, B., Yuan, W., Wang, C., Gao, R., & Wang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1825-0 · Cited by 25
Self-citationCIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion
Zhai, M., Cong, L., Han, Y., & Tu, G. (2013) · Tumor Biology · doi:10.1007/s13277-013-1150-z · Cited by 24
Chen, Q., Xu, W., Jiao, D., Wu, L., Song, J., Yan, J., & Shi, J. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1586-x · Cited by 24
Song, D., Ni, J., Xie, H., Ding, M., & Wang, J. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1571 · Cited by 21
Xu, G., Zhao, W., Zhuang, J., Zu, J., Wang, D., Han, F., Zhang, Z., & Yan, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2764-5 · Cited by 19
Array Comparative Genomic Hybridization in Osteosarcoma
Sadiković, B., Park, P. C., Selvarajah, S., & Zieleńska, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-281-0_15 · Cited by 17
Expression of ezrin, Bcl‐2, and Ki‐67 in chondrosarcomas
Söderström, M., Palokangas, T., Vahlberg, T. J., Böhling, T., Aro, H. T., & Carpén, O. (2010) · Apmis · doi:10.1111/j.1600-0463.2010.02656.x · Cited by 15
Lo Vasco, V. R., Leopizzi, M., Puggioni, C., & Della Rocca, C. (2014) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-014-0235-9 · Cited by 15
Ezrin promotes invasion and migration of the MG63 osteosarcoma cell
Zhang, J., Zuo, J., Lei, M., Wu, S., Zang, X., & Zhang, C. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132225 · Cited by 13
Self-citationNovel p53 splicing site mutation in Li‐Fraumeni‐like syndrome with osteosarcoma
Sakurai, N., Iwamoto, S., Miura, Y., Nakamura, T., Matsumine, A., Nishioka, J., Nakatani, K., & Komada, Y. (2013) · Pediatrics International · doi:10.1111/j.1442-200x.2012.03641.x · Cited by 10
Loftus, J. P., Cavatorta, D. J., Bushey, J. J., Levine, C. B., Sevier, C. S., & Wakshlag, J. J. (2014) · Veterinary and Comparative Oncology · doi:10.1111/vco.12094 · Cited by 10
Understanding susceptibility to breast cancer metastasis: the genetic approach
Shukla, A., Alsarraj, J., & Hunter, K. W. (2014) · Breast Cancer Management · doi:10.2217/bmt.14.1 · Cited by 7
Lu, X., Zhao, J., Li, T., Huang, M., Liang, J., & Wei, W. (2014) · Connective Tissue Research · doi:10.3109/03008207.2014.984064 · Cited by 5
Cancer stem-like cells: the dark knights of clinical hematology and oncology.
Frinc, I. C., Muresan, M.-S., Zaharie, F. V., Petrov, L., Irimie, A. I., Berce, C., Berindan‐Neagoe, I., & Tomuleasa, C. (2014) · PubMed · Cited by 4
Cited by
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundInfluentialTewari, D., Patni, P., Bishayee, A., Sah, A. N., & Bishayee, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.008 · Cited by 642
Bone Microenvironment and Osteosarcoma Metastasis
Yang, C., Tian, Y., Zhao, F., Chen, Z., Su, P., Li, Y., & Qian, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196985 · Cited by 291
Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy
Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G. E., Santucci, A., Vermi, W., & Giurisato, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155207 · Cited by 280
Tong, C., Wu, Y., Zhang, L., & Yu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1091147 · Cited by 157
Metadata
- Authors
- Zhang, J., Yu, X.-H., Yan, Y.-G., Wang, C., & Wang, W.-J.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 444
- Pages
- 182-192
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2063879050
- Cited by
- 327
- References
- 128
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.